Hologic Acquires Suros To Expand Its Breast Cancer Detection Offerings
This article was originally published in The Gray Sheet
Executive Summary
Hologic aims to break into the Johnson & Johnson-dominated breast biopsy market following its acquisition of Suros Surgical Systems